abstract |
A novel tetrahydropyran derivative crystal, a process for producing the crystal, and a pharmaceutical composition containing the crystal. Crystals of a compound of formula I, each with EtOH, ethylene glycol, 1: 2 L-proline and 1: 1 L-proline, 1: 1 L-proline hemihydrate A crystal selected from crystals. [Selection figure] None |